Skip to content

KRAIG BIOCRAFT LABORATORIES, INC.: 10-Q filed 2020-07-31

What KRAIG BIOCRAFT LABORATORIES, INC. reported in its quarterly report filed 2020-07-31 (fiscal Q2 2020): 23 published measures, 65 facts as tagged in accession 0001493152-20-014337.

This filing

Form
10-Q (quarterly report)
Filed
2020-07-31
Fiscal period
fiscal Q2 2020
Accession
0001493152-20-014337 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All KRAIG BIOCRAFT LABORATORIES, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2020-06-30586,152USD
At 2019-12-31750,850USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2020-06-306,899,755USD
At 2019-12-316,138,908USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2020-06-30-6,313,603USD
At 2019-12-31-5,388,058USD
At 2019-06-30-4,067,265USD
At 2018-12-31-4,459,223USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2020-04-01 to 2020-06-30-568,797USD91
2020-01-01 to 2020-06-30-3,620,136USD182
2019-04-01 to 2019-06-30-402,497USD91
2019-01-01 to 2019-06-30-880,243USD181

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2020-01-01 to 2020-06-30-697,909USD182
2019-01-01 to 2019-06-30-455,469USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2020-01-01 to 2020-06-30627,595USD182
2019-01-01 to 2019-06-301,116,000USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2020-06-30-33,418,042USD
At 2019-12-31-29,797,906USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2020-06-30104,203USD
At 2019-12-31117,321USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2020-04-01 to 2020-06-30-470,329USD91
2020-01-01 to 2020-06-30-3,434,993USD182
2019-04-01 to 2019-06-30-335,243USD91
2019-01-01 to 2019-06-30-747,253USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2020-06-3063,182USD
At 2019-12-31156,769USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2020-04-01 to 2020-06-3098,468USD91
2020-01-01 to 2020-06-30185,143USD182
2019-04-01 to 2019-06-3070,695USD91
2019-01-01 to 2019-06-30137,615USD181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2020-06-306,436,073USD
At 2019-12-315,584,383USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2020-04-01 to 2020-06-30470,329USD91
2020-01-01 to 2020-06-303,434,993USD182
2019-04-01 to 2019-06-30335,243USD91
2019-01-01 to 2019-06-30747,253USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2020-04-01 to 2020-06-3032,970USD91
2020-01-01 to 2020-06-3037,782USD182
2019-04-01 to 2019-06-3020,937USD91
2019-01-01 to 2019-06-3043,241USD181

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2020-06-305,107,560USD
At 2019-12-312,412,969USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2020-06-30415,249USD
At 2019-12-31473,242USD
At 2019-01-02529,135USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2020-06-30426,104USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2020-06-30126,787USD
At 2019-12-31113,669USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2020-04-01 to 2020-06-30-568,797USD91
2020-01-01 to 2020-06-30-3,620,136USD182
2019-04-01 to 2019-06-30-402,497USD91
2019-01-01 to 2019-06-30-880,243USD181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2020-04-01 to 2020-06-30348,278USD91
2020-01-01 to 2020-06-303,141,059USD182
2019-04-01 to 2019-06-30122,186USD91
2019-01-01 to 2019-06-30240,153USD181

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2020-04-01 to 2020-06-305,740USD91
2020-01-01 to 2020-06-3013,118USD182
2019-04-01 to 2019-06-306,738USD91
2019-01-01 to 2019-06-3013,403USD181

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2020-04-01 to 2020-06-30-98,468USD91
2020-01-01 to 2020-06-30-185,143USD182
2019-04-01 to 2019-06-30-67,254USD91
2019-01-01 to 2019-06-30-132,990USD181

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2019-01-01 to 2019-06-301,000,000USD181

Inspect the source

Entity
KRAIG BIOCRAFT LABORATORIES, INC. / CIK 0001413119
Captured
2026-09-20T08:02:08.774Z
SEC response SHA-256
920795b2181369f3ae04be68b2de22ae3d9ee7808a72922b976f9dc124464bc6

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001413119.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))